mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT05918250 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The Sponsor decided to discontinue development of mRNA-2736 for strategic business reasons.

Conditions

Interventions

Sponsor

ModernaTX, Inc.